bioXXmed AG (FRA:T5O) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T5O bioXXmed AG FRA:T5O
38 GF Score
Price €0.81
GF Value €10.79
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is bioXXmed AG Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:T5O vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, bioXXmed AG's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

bioXXmed AG Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bioXXmed AG's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where bioXXmed AG's Short Percentage of Float falls into.


FRA:T5O
38GF Score
bioXXmed AG FRA:T5O
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is bioXXmed AG (FRA:T5O) Overvalued in 2026?

Based on GuruFocus' analysis, bioXXmed AG stock appears to be undervalued. The current stock price of €0.81 is trading 92.5% below its estimated GF Value™ of €10.79. GuruFocus considers bioXXmed AG to be Possible Value Trap.

Key valuation signals for FRA:T5O:

  • Short Percentage of Float:
  • GF Value™: €10.79 vs. price of €0.81 (92.5% below fair value)
  • GF Score™: 38/100 with 3 warning signs

No single metric tells the full story. See the FRA:T5O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

bioXXmed AG Business Description

Other Exchanges T5O:Germany
Address Riedstrasse 2, Darmstadt, HE, DEU, 64295
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.
38GF Score

Get the complete analysis for FRA:T5O

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.81
Price
€10.79
GF Value